Table 2.
Gene ontology analysis of DEGs obtained from tea plants treated by sucrose after 2d
Pathway | DEGs genes | All genes | Q-value | |
---|---|---|---|---|
(3553) | (47655) | |||
1 | Flavonoid biosynthesis | 87 (2.45%) | 314 (0.66%) | 2.35E-25 |
2 | Biosynthesis of secondary metabolites | 530 (14.92%) | 4746 (9.96%) | 1.33E-20 |
3 | Phenylpropanoid biosynthesis | 124 (3.49%) | 653 (1.37%) | 1.76E-20 |
4 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | 63 (1.77%) | 233 (0.49%) | 3.38E-18 |
5 | Flavone and flavonol biosynthesis | 44 (1.24%) | 165 (0.35%) | 1.41E-12 |
6 | Phenylalanine metabolism | 52 (1.46%) | 234 (0.49%) | 1.76E-11 |
7 | Plant hormone signal transduction | 291 (8.19%) | 2615 (5.49%) | 4.76E-11 |
8 | Zeatin biosynthesis | 63 (1.77%) | 365 (0.77%) | 5.88E-09 |
9 | Cutin, suberine and wax biosynthesis | 30 (0.84%) | 116 (0.24%) | 1.65E-08 |
10 | Pentose and glucuronateinterconversions | 70 (1.97%) | 452 (0.95%) | 6.26E-08 |
11 | DNA replication | 44 (1.24%) | 244 (0.51%) | 4.79E-07 |
12 | Carotenoid biosynthesis | 40 (1.13%) | 212 (0.44%) | 4.95E-07 |
13 | Limonene and pinene degradation | 34 (0.96%) | 170 (0.36%) | 1.05E-06 |
14 | Metabolic pathways | 902 (25.39%) | 10,454 (21.94%) | 1.79E-06 |
15 | Ether lipid metabolism | 130 (3.66%) | 1142 (2.4%) | 8.47E-06 |
16 | Starch and sucrose metabolism | 129 (3.63%) | 1141 (2.39%) | 1.24E-05 |
17 | Diterpenoid biosynthesis | 22 (0.62%) | 105 (0.22%) | 6.04E-05 |
18 | Tryptophan metabolism | 22 (0.62%) | 107 (0.22%) | 7.84E-05 |
19 | Other glycan degradation | 47 (1.32%) | 328 (0.69%) | 8.46E-05 |
20 | Endocytosis | 156 (4.39%) | 1526 (3.2%) | 2.40E-04 |
21 | Glycerophospholipid metabolism | 160 (4.5%) | 1577 (3.31%) | 2.69E-04 |
22 | Glucosinolate biosynthesis | 15 (0.42%) | 64 (0.13%) | 3.18E-04 |
23 | Isoflavonoid biosynthesis | 15 (0.42%) | 72 (0.15%) | 1.25E-03 |
24 | Plant-pathogen interaction | 309 (8.7%) | 3440 (7.22%) | 1.60E-03 |
25 | Monoterpenoid biosynthesis | 10 (0.28%) | 41 (0.09%) | 3.38E-03 |
26 | Anthocyanin biosynthesis | 6 (0.17%) | 20 (0.04%) | 1.26E-02 |
27 | Cysteine and methionine metabolism | 40 (1.13%) | 339 (0.71%) | 1.27E-02 |
28 | Base excision repair | 29 (0.82%) | 228 (0.48%) | 1.51E-02 |
29 | Homologous recombination | 36 (1.01%) | 323 (0.68%) | 4.46E-02 |